FDA Inspection
Zhejiang Jingxin Pharmaceutical Co., Ltd.Zhejiang Jingxin Pharmaceutical Co., Ltd. – FDA Inspection, Nov 9, 2018
Record Details
This FDA Inspection record concerns Zhejiang Jingxin Pharmaceutical Co., Ltd., with an inspection on November 9, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- November 9, 2018
- Product Type
- Human Drugs
View Company Profile
ID · ad1118c1-ef12-4812-aefb-0d7f8ef6bbb2
Inspection Facts
- Inspection number
- 1074667
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Jingxin Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| June 21, 2024 | Not classified | Office of Inspections and Investigations |
Other documents for Zhejiang Jingxin Pharmaceutical Co., Ltd.
- FDA Inspection 1290202 - 2025-10-17
- FDA Inspection 1243909 - 2024-06-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.